Lyka Labs Limited (NSE India Code : LYKALABS)       BUY

Company Name :
 NSE SYMBOL :  
Enter Company Name or NSE Code

LYKALABS Technical Levels

Resistance 2 11.57
Resistance 1 11.38
PIVOT 11.07
Support 1 10.88
Support 2 10.38

LYKALABS Fundamentals

Earning Growth -99.99%
Profit Margin -11.27
PE -2.67
EPS -4.97
Quarter 30-Sep-11

LYKALABS Futures

Close
Contracts Traded
Open Interest(OI)
Change in OI
Lot Size

LYKALABS Options

Most Active Call
Most Active Put
Highest OI Call
Highest OI Put
Expiry Date

LYKALABS Technical Levels


Other Stocks from Pharmaceuticals Sector  AARTIDRUGS   ABBOTINDIA   AJANTPHARM   ALCHEM   ALKALI   ALPA   AMRUTANJAN   ANKURDRUGS   ARL   ASTRAZEN   AUROPHARMA   AVENTIS   BALPHARMA   BIOCON   BLISSGVS   CADILAHC   CELESTIAL   CIPLA   DISHMAN   DIVISLAB   DRREDDY   ELDERPHARM   FDC   FKONCO   GLAXO   GLENMARK   GRANULES   INDOCO   INDSWFTLAB   INDSWFTLTD   IPCALAB   JAGSNPHARM   JBCHEPHARM   JUBILANT   KILITCH   KOPRAN   LUPIN   LYKALABS   MANGALAM   MERCK   MOREPENLAB   NATCOPHARM   NECLIFE   NEULANDLAB   OPTOCIRCUI   ORCHIDCHEM   PANACEABIO   PARABDRUGS   PFIZER   PIRHEALTH 

LYKALABS Share Price on 5-10-2012

Open 11.5
High 11.5
Low 11.1
Close 11.1
Volume 11100
Change -0.2 (-1.77%)
Series EQ
Date of Listing 08-Feb-95
Paid Up Value 10
Face Value 10
Market Capital 0 Crores
52 Week High/Low 15.45 / 8.15
Get share widget

Lyka Labs Limited Company Profile

LYKA is one of the leading health care companies established in 1976. The main business profile of the company is formulations, medical diagnostics and veterinary medicines. It has also forayed into animal health care products. It is recognised as EXPORT HOUSE by the Government of India. The company has two manufacturing plants located at Ankleshwar in Gujarat and Tarapur in Maharashtra. Its products encompass a wide range of therapeutic segments which include anti-bacterials, anti-tubercular, anti-cancer, anti-ulcerants, dermatological, cardiovascular, cough and cold preparations, pain management etc. It has penetrated into the international market and is catering to the needs of more than 25 countries. It serves institutions like World Health Organisation (WHO) and through World Bank, it supplies ANTI-TB drugs to various countries like Bangladesh, Myanmar and Vietnam. It also receives a substantial amount of business from the ministries of health of various overseas countries such as Sri Lanka, Sudan, Myanmar and Mauritius. LYKA's products are registered in South East Asia, Eastern Europe, East Africa, West Africa, Middle East etc. In appreciation of its export performance, LYKA has received various awards from time to time. LYKA has a full fledged research and development centre which is recognized by the department of science and technology, Government of India. It is certificate with ISO 9001:2000. LYKA is also interested in contract manufacturing products for overseas buyers under their brand names. Other specific proposals such as providing technical know-how, joint ventures and supply of products in bulk are also undertaken by LYKA.

LYKALABS Intraday Realtime Chart

LYKALABS Corporate Announcements

DATE PURPOSE
03-Jul-12 Extension of Annual General Meeting
15-May-12 Financial Result Updates
04-May-12 Disclosure under SEBI Takeover Regulations
03-Apr-12 Appointment of Director
30-Mar-12 Outcome of Board Meeting

LYKALABS Corporate Actions

DATE PURPOSE
26-Sep-12 Annual General Meeting
20-Apr-11 Annual General Meeting
20-Apr-11 Annual General Meeting

LYKALABS Board Meetings

MEETING DATE PURPOSE
14-Aug-12 Un-audited Financial Results
15-May-12 Un-audited Financial Results
29-Mar-12 Miscelleneous
14-Feb-12 Un-audited Financial Results
14-Nov-11 Un-audited Financial Results

LYKALABS Related companies

Symbol Company Name
AARTIDRUGS Aarti Drugs Limited
ABBOTINDIA Abbott India Limited
AJANTPHARM Ajanta Pharma Limited
ALCHEM Alchemist Limited
ALKALI Alkali Metals Limited

Most Active NSE INDIA Stocks

 HDFC   LITL   IVRCLINFRA   HDIL   UNITECH   JPASSOCIAT   GVKPIL   TATAMOTORS   IFCI   IBREALEST   ESSAROIL   GMRINFRA   BIRLAPOWER   HINDALCO   BHEL   RENUKA   RCOM   DLF   SUZLON   RELCAPITAL   IDFC   ADANIENT   ITC   TATAPOWER   BALLARPUR 

Free Stock Market Tips:

VJonDalalStreet Paid Tips

Home
Stock Market IPO
Mutual Funds
Education Paid Service
About us
Share Market
IPO Watch
MF News
IPO
Subscription
VJonDalalStreet
Technical Analysis
New IPO Review
Old Funds
Articles
Equity Performance
DalalStreet Blog
Stock Market News Indian IPO News
New Funds
Stock Market
Futures Performance
Free Sms Alerts
World Stock Market
IPO Allotment Status
Best Funds
Financial Terms
Options Performance
Privacy Stock Recommendations
Grey Market Premium MF Analysis Futures & Options Jackpot Performance
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither VJonDalalStreet.com website nor any of its promoters shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes acceptance of our Disclaimer
Follow VJonDalalStreet on Facebook Follow VJonDalalStreet on Twitter Follow VJonDalalStreet Blog Email VJonDalalStreet